2008-09-01
National Heart, Lung, and Blood Institute (NHLBI) Director Elizabeth
Nabel, MD, has announced that Dr. W. Keith Hoots will assume the
position of Senior Advisor to the Director for Blood Diseases at NHLBI
effective January 5, 2009. In this capacity, Dr. Hoots will serve as
liaison to NHLBI's Division of Blood Diseases and Resources.
Dr. Hoots is a longstanding ASH member with expertise in the
management and diagnosis of congenital and acquired bleeding and
clotting disorders. He is currently Professor of Pediatrics and
Division Head of Pediatric Hematology at The University of Texas
Medical School at Houston, Section Head of Pediatric Hematology at M.
D. Anderson Cancer Center, and Medical Director of the Gulf States
Hemophilia and Thrombophilia Treatment Center. His work includes the
creation of longitudinal follow-up of hemophilia cohorts with HIV and
hepatitis, gene therapy trials for hemophilia A and B, clinical trials
of new clotting concentrates for hemophilia A and B, and the impact of
care and clotting factor product on hemophilia patient outcome.
Dr. Hoots will replace Dr. Charles Peterson, who retired earlier this year.
Look for a more in-depth article on Dr. Hoots in the November/December issue.
back to top
